MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment

被引:6
|
作者
Cohen, YC [1 ]
Hassin-Baer, S
Olmer, L
Barishev, R
Goldhammer, Y
Freedman, L
Mozes, B
机构
[1] Chaim Sheba Med Ctr, Gertner Inst Hlth Policy Res, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel
来源
MULTIPLE SCLEROSIS | 2000年 / 6卷 / 05期
关键词
EDSS; FSS; multiple sclerosis; reliability;
D O I
10.1177/135245850000600511
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Kurtzke's EDSS remains the most widely-used measure for clinical evaluation of MS patients. However, several studies have demonstrated the limited reliability of this tool. We introduce a computerized instrument, MS-CANE (Multiple Sclerosis Computer-Aided Neurological Examination), for clinical evaluation and follow up of patients with multiple sclerosis (MS) and to compare its reliability to that of conventional Expanded Disability Status Scale (EDSS) assessment We developed a computerized interactive instrument based on the following principles: structured gathering of neurological findings, reduction of compound notions to their basic components use of precise definitions priority setting and automated calculations of EDSS and functional systems scores. An expert panel examined the consistency of MS-CANE with Kurtzke's specifications. To determine the effect of MS-CANE on the reliability of EDSS assessment, 56 MS patients underwent paired conventional EDSS and MS-CANE-based evaluations. The inter-observer agreement in both methods was determined and compared using the kappa statistic The expert panel judged the tool to be compatible with the basic concepts of Kurtzke's EDSS. The use of MS-CANE increased the reliability of EDSS assessment Kappa statistic was found to be 0.42 (i.e. moderate agreement) for conventional EDSS assessment versus 0.69 (i.e. substantial agreement) for MS-CANE (P=0.002). We conclude that the use of this tool may contribute towards a standardized and reliable assessment of EDSS. Within clinical trials this could increase the power to detect effects, thus reducing trial duration and the cohort size required.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 26 条